학술논문

410O_PR - Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study
Document Type
Abstract
Source
In Annals of Oncology November 2017 28 Supplement 10:x191-x191
Subject
Language
ISSN
0923-7534